Scandinavian cardiovascular journal : SCJ
-
Scand. Cardiovasc. J. · Dec 2020
SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
The inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with presence and severity of coronary artery disease (CAD) and incident death and myocardial infarction (MI). We sought to validate this finding in a further cohort of patients with suspected CAD. ⋯ We demonstrate that the inflammatory biomarker soluble urokinase plasminogen activator receptor is an independent predictor of death/myocardial infarction in patients with suspected or known coronary artery disease, but is not associated with the presence or severity of coronary artery disease.